Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, T. Norene O’Sullivan et al.|Molecular Cancer Therapeutics|2021Cited by 6
CD8 T-cell dysfunction is linked with CAR T-cell failure and can be mitigated by a non-alpha IL-2 agonist, pegenzileukinPatrick K. Reville, Michael R. Green, Robin Meng et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1
Supplementary Figure Legends from Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, T. Norene O’Sullivan et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, T. Norene O’Sullivan et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, T. Norene O’Sullivan et al.|Unknown|2023Cited by 0